(Q41528803)

1

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Second Tumors in Nonirradiated Bilateral Retinoblastoma

14 September 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice

14 September 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.

14 September 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F

14 September 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 is a nuclear protein required for cell cycle progression in G1

14 September 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor

14 September 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin A and the retinoblastoma gene product complex with a common transcription factor

14 September 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F.

14 September 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 protein expression and function in human breast cancer

14 September 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas

14 September 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain

14 September 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo

14 September 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Human retinoblastoma gene: long-range mapping and analysis of its deletion in a breast cancer cell line

14 September 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

14 September 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular genetics of the retinoblastoma suppressor gene

14 September 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter.

14 September 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

14 September 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Expression and amplification of cyclin genes in human breast cancer

14 September 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein

14 September 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

14 September 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.

14 September 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product

14 September 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

14 September 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

14 September 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The E2F transcription factor is a cellular target for the RB protein

14 September 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product

14 September 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

14 September 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator

14 September 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

14 September 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6

14 September 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein

14 September 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Requirement for a functional Rb-1 gene in murine development

14 September 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Thymocyte apoptosis induced by p53-dependent and independent pathways.

14 September 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

14 September 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle-specific association of E2F with the p130 E1A-binding protein

14 September 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types

14 September 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas

14 September 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle regulation of the human cdc2 gene

14 September 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

14 September 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

14 September 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.

14 September 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.

14 September 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase

14 September 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis

14 September 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Physical interaction of the retinoblastoma protein with human D cyclins

14 September 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification of germline and somatic mutations affecting the retinoblastoma gene

14 September 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-induced S phase requires cyclin E.

14 September 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Differential regulation of E2F transactivation by cyclin/cdk2 complexes

14 September 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus

14 September 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor

14 September 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

WAF1, a potential mediator of p53 tumor suppression

14 September 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype

14 September 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen

14 September 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Induction of apoptosis in fibroblasts by c-myc protein

14 September 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein

14 September 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins

14 September 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

14 September 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein

14 September 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interaction between human cyclin A and adenovirus E1A-associated p107 protein

14 September 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The adenovirus E1A-associated kinase consists of cyclin E-p33cdk2 and cyclin A-p33cdk2.

14 September 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-1 functions in mice to promote apoptosis and suppress proliferation

14 September 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes

14 September 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product

14 September 2024

73

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme

14 September 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death

14 September 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

14 September 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein

14 September 2024

77

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice

14 September 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Structural evidence for the authenticity of the human retinoblastoma gene

14 September 2024

81

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases

14 September 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Evidence for a protein domain superfamily shared by the cyclins, TFIIB and RB/p107.

14 September 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining

14 September 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-4, a new member of the E2F transcription factor family, interacts with p107

14 September 2024

87

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Human cyclin A and the retinoblastoma protein interact with similar but distinguishable sequences in the adenovirus E1A gene product

14 September 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A new component of the transcription factor DRTF1/E2F.

14 September 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

14 September 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle

14 September 2024

93

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular characterization of the retinoblastoma susceptibility gene

14 September 2024

94

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation

14 September 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

14 September 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

14 September 2024

97

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation

14 September 2024

98

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes

14 September 2024

99

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of apoptosis by the retinoblastoma gene product.

14 September 2024

100

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB

14 September 2024

101

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Apoptosis: molecular regulation of cell death

14 September 2024

102

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

14 September 2024

103

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins

14 September 2024

105

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

14 September 2024

106

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

14 September 2024

107

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

14 September 2024

108

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

14 September 2024

109

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of cyclin-dependent kinases by p21

14 September 2024

110

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle control and cancer

14 September 2024

111

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody

14 September 2024

112

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein

14 September 2024

113

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Induction of apoptosis in HeLa cells by trans-activation-deficient p53

14 September 2024

114

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines

14 September 2024

115

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F

14 September 2024

116

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein

14 September 2024

117

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation

14 September 2024

118

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen

14 September 2024

119

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Structure and cell cycle-regulated transcription of the human cyclin A gene

14 September 2024

120

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers

14 September 2024

123

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts

14 September 2024

124

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F

14 September 2024

125

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression

14 September 2024

126

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-5, a new E2F family member that interacts with p130 in vivo

14 September 2024

127

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

14 September 2024

128

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Participation of cyclin A in Myc-induced apoptosis.

14 September 2024

130

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma

14 September 2024

131

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

14 September 2024

133

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A

14 September 2024

134

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53

14 September 2024

135

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter

14 September 2024

136

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

14 September 2024

138

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins

14 September 2024

140

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

14 September 2024

141

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Germline p16 mutations in familial melanoma

14 September 2024

142

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein

14 September 2024

143

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines

14 September 2024

144

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation

14 September 2024

145

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes

14 September 2024

146

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Effects of an Rb mutation in the mouse

14 September 2024

148

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amplification and expression of the human cyclin D gene in esophageal cancer

14 September 2024

149

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer

14 September 2024

151

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Expression of transcription factor E2F1 induces quiescent cells to enter S phase

14 September 2024

153

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression

14 September 2024

154

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Oncogenic capacity of the E2F1 gene

14 September 2024

155

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product

14 September 2024

157

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product

14 September 2024

158

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

14 September 2024

159

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Domains of E1A that bind p105Rb, p130, and p300 are required to block nerve growth factor-induced neurite growth in PC12 cells

14 September 2024

160

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A cell cycle regulator potentially involved in genesis of many tumor types

14 September 2024

161

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell-cycle regulators and cancer

14 September 2024

162

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

14 September 2024

163

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1

14 September 2024

164

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene

14 September 2024

166

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma gene product regulates Sp1-mediated transcription

14 September 2024

167

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2

14 September 2024

168

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts

14 September 2024

169

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression

14 September 2024

170

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

14 September 2024

171

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Mutation and cancer: statistical study of retinoblastoma

14 September 2024

172

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

14 September 2024

173

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transcriptional control by the retinoblastoma protein

14 September 2024

174

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification of a cellular transcription factor involved in E1A trans-activation

14 September 2024

175

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis.

14 September 2024

176

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 is an essential mediator of apoptotic neuronal cell death.

14 September 2024

177

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members

14 September 2024

178

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase

14 September 2024

179

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control

14 September 2024

180

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

14 September 2024

181

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Chromosome 11q13 abnormalities in human cancer

14 September 2024

183

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

T antigen is bound to a host protein in SY40-transformed cells

14 September 2024

185

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins

14 September 2024

186

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases

14 September 2024

187

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53 Mutation and MDM2 amplification in human soft tissue sarcomas

14 September 2024

188

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amplification of cyclin genes in colorectal carcinomas

14 September 2024

189

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inactivation of the retinoblastoma susceptibility gene in human breast cancers

14 September 2024

190

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

14 September 2024

191

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation

14 September 2024

192

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle

14 September 2024

194

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

14 September 2024

195

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Human retinoblastoma susceptibility gene: cloning, identification, and sequence

14 September 2024

196

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

14 September 2024

197

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner

14 September 2024

198

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein binds to a family of E2F transcription factors

14 September 2024

199

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Ras-regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells

14 September 2024

200

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

14 September 2024

201

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E

14 September 2024

202

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

14 September 2024

204

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

14 September 2024

205

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53 is required for radiation-induced apoptosis in mouse thymocytes

14 September 2024

206

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family

14 September 2024

207

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1

14 September 2024

208

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines

14 September 2024

209

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

14 September 2024

211

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

14 September 2024

212

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control

14 September 2024

213

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

14 September 2024

214

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

14 September 2024

215

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage

14 September 2024

216

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

14 September 2024

217

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle

14 September 2024

218

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

14 September 2024

219

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

D-type cyclin-dependent kinase activity in mammalian cells

14 September 2024

220

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53.

14 September 2024

221

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Growth suppression by p16ink4 requires functional retinoblastoma protein

14 September 2024

222

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

14 September 2024

223

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

14 September 2024

225

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

14 September 2024

226

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interferon-gamma modulates retinoblastoma gene mRNA in monocytoid cells

14 September 2024

227

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

14 September 2024

229

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

14 September 2024

230

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Principles of CDK regulation

14 September 2024

231

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.

14 September 2024

232

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A novel cyclin encoded by a bcl1-linked candidate oncogene

14 September 2024

233

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint

14 September 2024

234

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

14 September 2024

235

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 expression is regulated by the retinoblastoma protein

14 September 2024

236

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transcriptional regulation during the mammalian cell cycle

14 September 2024

237

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition

14 September 2024

239

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter

14 September 2024

240

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

14 September 2024

241

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

14 September 2024

242

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen

14 September 2024

243

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

14 September 2024

244

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1

14 September 2024

245

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins

14 September 2024

246

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin-dependent regulation of G1 in mammalian fibroblasts.

14 September 2024

248

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

14 September 2024

249

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amplification of a gene encoding a p53-associated protein in human sarcomas

14 September 2024

250

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

14 September 2024

251

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle

14 September 2024

253

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Association of cdk2 Kinase with the Transcription Factor E2F During S Phase

14 September 2024

254

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development

14 September 2024

255

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development

14 September 2024

256

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A Restriction Point for Control of Normal Animal Cell Proliferation

14 September 2024

257

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

G1 events and regulation of cell proliferation

14 September 2024

258

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

14 September 2024

260

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells

14 September 2024

262

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product

14 September 2024

263

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

14 September 2024

264

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

14 September 2024

Cyclins, CDKs and cancer

265

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions

14 September 2024

266

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells

14 September 2024

267

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

14 September 2024

268

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

14 September 2024

269

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding

14 September 2024

270

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Identification of a growth suppression domain within the retinoblastoma gene product

14 September 2024

271

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis

14 September 2024

272

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The transcription factor E2F-1 is a downstream target of RB action

14 September 2024

273

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts

14 September 2024

274

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins

14 September 2024

276

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Bcl-2 and the regulation of programmed cell death

14 September 2024

277

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells

14 September 2024

279

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

14 September 2024

280

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells

14 September 2024

281

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

14 September 2024

283

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Negative regulation of human c-fos expression by the retinoblastoma gene product

14 September 2024

284

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein modulates expression of genes coding for diverse classes of proteins including components of the extracellular matrix

14 September 2024

285

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product

14 September 2024

286

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein

14 September 2024

287

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen

14 September 2024

288

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene

14 September 2024

289

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

14 September 2024

290

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle

14 September 2024

291

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

14 September 2024

292

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells

14 September 2024

295

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site

14 September 2024

296

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase

14 September 2024

298

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

14 September 2024

299

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Role of the INK4a locus in tumor suppression and cell mortality.

14 September 2024

300

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F

14 September 2024

301

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis

14 September 2024

302

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The transcription factor E2F-1 mediates the autoregulation of RB gene expression

14 September 2024

303

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis

14 September 2024

304

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250

14 September 2024

305

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

14 September 2024

Mammalian G1 cyclins

307

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

G1 phase progression: cycling on cue

14 September 2024

308

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

14 September 2024

D-type cyclins

309

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibitors of mammalian G1 cyclin-dependent kinases

14 September 2024

310

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas

14 September 2024

311

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A non-enzymatic p21 protein inhibitor of stress-activated protein kinases

14 September 2024

313

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner

14 September 2024

314

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

14 September 2024

316

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Transcriptional regulation of the dihydrofolate reductase gene

14 September 2024

318

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

14 September 2024

319

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

14 September 2024

320

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Detection of a novel cell cycle-regulated kinase activity that associates with the amino terminus of the retinoblastoma protein in G2/M phases

14 September 2024

323

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

14 September 2024

325

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis

14 September 2024

326

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Unrestricted cell cycling and cancer

14 September 2024

327

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53-dependent apoptosis suppresses tumor growth and progression in vivo

14 September 2024

328

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses

14 September 2024

329

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Structural rearrangement of the retinoblastoma gene in human breast carcinoma

14 September 2024

330

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

14 September 2024

331

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms

14 September 2024

333

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein

14 September 2024

334

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma

14 September 2024

335

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression

14 September 2024

336

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

14 September 2024

337

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas

14 September 2024

338

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression

14 September 2024

339

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression

14 September 2024

340

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regulation of the cell cycle by viral oncoproteins

14 September 2024

343

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

14 September 2024

344

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein

14 September 2024

345

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

14 September 2024

347

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen

14 September 2024

349

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The retinoblastoma protein and cell cycle control

14 September 2024

351

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Retinoblastoma protein switches the E2F site from positive to negative element

14 September 2024

352

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Mechanism of active transcriptional repression by the retinoblastoma protein

14 September 2024

353

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle

14 September 2024

354

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms

14 September 2024

355

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

14 September 2024

356

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins.

14 September 2024

358

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins

14 September 2024

359

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor α

14 September 2024

360

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Life, death, and the pursuit of apoptosis.

14 September 2024

361

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Repression of RNA polymerase III transcription by the retinoblastoma protein

14 September 2024

362

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Retinoblastoma in transgenic mice

14 September 2024

364

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

14 September 2024

365

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

In vivo association of E2F and DP family proteins

14 September 2024

366

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration

14 September 2024

367

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p53 and E2F-1 cooperate to mediate apoptosis

14 September 2024

368

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Interaction between the retinoblastoma protein and the oncoprotein MDM2

14 September 2024

369

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p21 is a universal inhibitor of cyclin kinases

14 September 2024

370

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Multiple members of the E2F transcription factor family are the products of oncogenes

14 September 2024

371

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation

14 September 2024

372

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Tumor induction and tissue atrophy in mice lacking E2F-1

14 September 2024

373

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1

14 September 2024

374

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression.

14 September 2024

376

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity

14 September 2024

379

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p21-containing cyclin kinases exist in both active and inactive states

14 September 2024

380

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma

14 September 2024

381

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells

14 September 2024

382

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells

14 September 2024

383

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein

14 September 2024

384

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.

14 September 2024

386

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins

14 September 2024

387

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cell cycle regulation of E2F site occupation in vivo.

14 September 2024

388

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X

Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit

14 September 2024

389

1 reference

https://api.crossref.org/works/10.1111/J.1432-1033.1997.T01-2-00581.X